| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 4837-4843, Copyright © 1996 by Endocrine Society
ARTICLES |
SY Hsu, RJ Lai, M Finegold and AJ Hsueh
Department of Gynecology and Obstetrics, Stanford University School of Medicine, California 94305-5317, USA.
We have generated transgenic mice overexpressing Bcl-2, an apoptosis suppression protein, in ovarian cells using the inhibit-alpha gene promoter/enhancer. Ovarian apoptotic DNA fragmentation induced in immature animals by a low dose (2 IU) of PMSG was suppressed by greater than 55% in transgenic mice compared to their wild-type littermates. Morphological and in situ DNA end-labeling analyses showed that granulosa cells in large antral follicles of wild-type animals undergo apoptosis, but most follicles in transgenic animals are healthy. When the animals were treated with a high dose (4 IU) of PMSG to stimulate follicular growth, spontaneous ovulation was observed in 14 of 23 (61%) of the transgenic animals, but in only 3 of 18 (17%) of wild-type siblings. Furthermore, transgenic females had a larger litter size (9.07 +/- 0.25 pups/litter; n = 29) than wild-type controls (7.54 +/- 0.26 pups/litter; n = 28; P < 0.01). These data suggested that decreased ovarian apoptosis in transgenic animals could lead to enhanced folliculogenesis and ovulatory potential. Moreover, aging transgenic mice are susceptible to the development of benign cystic ovarian teratoma (4 in 20 transgenic animals and 0 in 26 wild-type controls). Some tumor tissues showed respiratory and intestinal cell types, whereas others showed the development of central nervous system- like structures. Because the bcl-2 transgene in these animals is overexpressed in somatic cells, but not oocytes, these findings suggest that enhanced survival of selected somatic cells in transgenic mice could lead to germ cell tumorigenesis. Thus, overexpression of Bcl-2 protein in the ovary leads to decreased ovarian somatic cell apoptosis, enhanced folliculogenesis, and increased susceptibility to ovarian germ cell tumorigenesis in transgenic animals. The present mouse model allows future studies on intracellular signal pathways regulating follicular atresia and on the potential role of ovarian somatic cell factors in germ cell tumorigenesis.
This article has been cited by other articles:
 |
|
 |
|
  S. A. Williams and P. Stanley Mouse fertility is enhanced by oocyte-specific loss of core 1-derived O-glycans FASEB J, July 1, 2008; 22(7): 2273 - 2284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A L Johnson, C. Ratajczak, M. J Haugen, H.-K. Liu, and D. C Woods Tumor necrosis factor-related apoptosis inducing ligand expression and activity in hen granulosa cells Reproduction, March 1, 2007; 133(3): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R Greenfeld, J. K Babus, P. A Furth, S. Marion, P. B Hoyer, and J. A Flaws BAX is involved in regulating follicular growth, but is dispensable for follicle atresia in adult mouse ovaries Reproduction, January 1, 2007; 133(1): 107 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Morales, I. Gonzalez-Robayna, M. P. Santana, I. Hernandez, and L. F. Fanjul Tumor Necrosis Factor-{alpha} Activates Transcription of Inducible Repressor Form of 3',5'-Cyclic Adenosine 5'-Monophosphate-Responsive Element Binding Modulator and Represses P450 Aromatase and Inhibin {alpha}-Subunit Expression in Rat Ovarian Granulosa Cells by a p44/42 Mitogen-Activated Protein Kinase-Dependent Mechanism Endocrinology, December 1, 2006; 147(12): 5932 - 5939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws Ovarian follicle development and transgenic mouse models Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Miller, R. K. Gupta, C. R. Greenfeld, J. K. Babus, and J. A. Flaws Methoxychlor Directly Affects Ovarian Antral Follicle Growth and Atresia through Bcl-2- and Bax-Mediated Pathways Toxicol. Sci., November 1, 2005; 88(1): 213 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Hussein Apoptosis in the ovary: molecular mechanisms Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tomic, K. P. Miller, H. A. Kenny, T. K. Woodruff, P. Hoyer, and J. A. Flaws Ovarian Follicle Development Requires Smad3 Mol. Endocrinol., September 1, 2004; 18(9): 2224 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, and T. C. Hamilton Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer Cancer Res., March 15, 2003; 63(6): 1389 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Hartley, R. A. L. Bayne, L. L. L. Robinson, N. Fulton, and R. A. Anderson Developmental Changes in Expression of Myeloid Cell Leukemia-1 in Human Germ Cells during Oogenesis and Early Folliculogenesis J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3417 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Embree-Ku and K. Boekelheide Absence of p53 and FasL Has Sexually Dimorphic Effects on Both Development and Reproduction Experimental Biology and Medicine, July 1, 2002; 227(7): 545 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Vaskivuo, M. Anttonen, R. Herva, H. Billig, M. Dorland, E. R. te Velde, F. Stenback, M. Heikinheimo, and J. S. Tapanainen Survival of Human Ovarian Follicles from Fetal to Adult Life: Apoptosis, Apoptosis-Related Proteins, and Transcription Factor GATA-4 J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3421 - 3429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Pru and J. L. Tilly Programmed Cell Death in the Ovary: Insights and Future Prospects Using Genetic Technologies Mol. Endocrinol., June 1, 2001; 15(6): 845 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Chun, H.-W. Bae, W.-J. Kim, J.-H. Park, S. Y. Hsu, and A. J. W. Hsueh Expression of Messenger Ribonucleic Acid for the Antiapoptosis Gene P11 in the Rat Ovary: Gonadotropin Stimulation in Granulosa Cells of Preovulatory Follicles Endocrinology, June 1, 2001; 142(6): 2311 - 2317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Flaws, A. N. Hirshfield, J. A. Hewitt, J. K. Babus, and P. A. Furth Effect of Bcl-2 on the Primordial Follicle Endowment in the Mouse Ovary Biol Reprod, April 1, 2001; 64(4): 1153 - 1159. [Abstract] [Full Text]
|
|
|
|
|
|
A.-C. Hägglund, P. Basset, and T. Ny Stromelysin-3 Is Induced in Mouse Ovarian Follicles Undergoing Hormonally Controlled Apoptosis, but This Metalloproteinase Is Not Required for Follicular Atresia Biol Reprod, February 1, 2001; 64(2): 457 - 463. [Abstract] [Full Text]
|
|
|
|
|
|
M. José de los Santos, D. J. Anderson, C. Racowsky, and J. A. Hill Presence of Fas-Fas Ligand System and Bcl-2 Gene Products in Cells and Fluids from Gonadotropin-Stimulated Human Ovaries1 Biol Reprod, December 1, 2000; 63(6): 1811 - 1816. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Gordo, H. Wu, C. L. He, and R. A. Fissore Injection of Sperm Cytosolic Factor Into Mouse Metaphase II Oocytes Induces Different Developmental Fates According to the Frequency of [Ca2+]i Oscillations and Oocyte Age Biol Reprod, May 1, 2000; 62(5): 1370 - 1379. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Y. Hsu and A. J. W. Hsueh Tissue-Specific Bcl-2 Protein Partners in Apoptosis: An Ovarian Paradigm Physiol Rev, April 1, 2000; 80(2): 593 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Johnson Editorial: Mcl-1--Just Another Antiapoptotic Bcl-2 Homolog? Endocrinology, December 1, 1999; 140(12): 5465 - 5468. [Full Text]
|
|
|
|
|
|
C. P. Leo, S. Y. Hsu, S.-Y. Chun, H.-W. Bae, and A. J. W. Hsueh Characterization of the Antiapoptotic Bcl-2 Family Member Myeloid Cell Leukemia-1 (Mcl-1) and the Stimulation of Its Message by Gonadotropins in the Rat Ovary Endocrinology, December 1, 1999; 140(12): 5469 - 5477. [Abstract] [Full Text]
|
|
|
|
|
|
J.-M. Kim, Y.-D. Yoon, and B. K. Tsang Involvement of the Fas/Fas Ligand System in p53-Mediated Granulosa Cell Apoptosis during Follicular Development and Atresia Endocrinology, May 1, 1999; 140(5): 2307 - 2317. [Abstract] [Full Text]
|
|
|
|
|
|
S. Y. Hsu, P. Lin, and A. J. W. Hsueh BOD (Bcl-2-Related Ovarian Death Gene) Is an Ovarian BH3 Domain-Containing Proapoptotic Bcl-2 Protein Capable of Dimerization with Diverse Antiapoptotic Bcl-2 Members Mol. Endocrinol., September 1, 1998; 12(9): 1432 - 1440. [Abstract] [Full Text]
|
|
|
|
|
|
A. Kaipia, S. Y. Hsu, and A. J. W. Hsueh Expression and Function of a Proapoptotic Bcl-2 Family Member Bcl-XL/Bcl-2-Associated Death Promoter (BAD) in Rat Ovary Endocrinology, December 1, 1997; 138(12): 5497 - 5504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Hsu, A. Kaipia, E. McGee, M. Lomeli, and A. J. W. Hsueh Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members PNAS, November 11, 1997; 94(23): 12401 - 12406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Amsterdam and N. Selvaraj Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes Endocr. Rev., August 1, 1997; 18(4): 435 - 461. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
